Actualités

Wells Fargo (WFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JPMorgan Chase & Co. (JPM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Goldman (GS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Citigroup (C) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Intel’s CEO said this week that the chip maker may return to the memory market, potentially making it a challenger to Micron and SK Hynix.

Sandisk has $35 billion burning a hole in its pocket. How will Sandisk spend it?

Can FIX's record backlog strengthen revenue visibility as Technology demand and expanding Modular capacity support growth into 2027?

Fast-food chains scramble to resonate with younger consumers through new cold drink lines

GM's 13.1% monthly gain reflects stronger core operations, improving earnings prospects and growth in software and digital services.

Meta Platforms (NASDAQ:META) says it has taken down 756,000 accounts it believes belonged to Australians under 16 since a nationwide ban on teen social media use took effect on December 10. The company disclosed the figure on August 13, splitting it into 462,000 suspect Instagram accounts and 294,000 Facebook accounts removed between December and June. […]

Bill Ackman of Pershing Square just told his investors he bought Netflix (NASDAQ:NFLX). The stock is down about 35% over the past year and 15% so far this year. Ackman said in his letter to investors that Netflix has already won the streaming wars. The company has more than 325 million subscribers, almost double what […]

MongoDB (MDB) is expected to see continued Atlas growth when it reports fiscal Q2 results, with inve

The stock is priced on a multi-year fab build-out whose pace is set by supply chains rather than by demand.

September and October can be rough for stocks. Here’s how to add some shock absorbers to your portfolio.

GE's defense momentum continues as rising demand, major contracts and a strong project pipeline lift revenues, orders and profit.

CMG's Q2 traffic gains and low-single-digit 2026 comp outlook signal recovery, but softer Q3 trends could test its momentum.

Energy Fuels is advancing a mine-to-magnet rare earth strategy with its ASM deal, VAC acquisition plans and White Mesa expansion.

IBM's $240 million Together AI deal is set to expand AI cloud infrastructure with NVIDIA systems, targeting high-performance inference and long-term growth.

SpaceX is planning a Texas natural gas plant to power a new chip facility, while gas turbines are already being used for campuses in Tennessee and Mississippi.

European equities traded in the US as American depositary receipts were higher late Thursday morning

Advanced Micro Devices Inc. is planning to raise as much $5 billion in what could be the chipmaker’s biggest-ever investment-grade bond sale, adding to a wave of debt tied to the artificial intelligence boom.

IREN Limited recently confirmed that Horizon 1, the first of four 50MW direct-to-chip liquid-cooled AI cloud deployments, has been delivered to and accepted by Microsoft under their five-year, US$9.70 billion cloud services contract. In parallel, IREN secured NVIDIA Exemplar Cloud status for its GB300 NVL72 deployment at Horizon 1, underscoring its capability to run high-performance AI workloads at scale for hyperscale customers. We’ll now explore how Microsoft’s acceptance of Horizon 1...

In early August 2026, Pfizer Inc. reported second-quarter results showing revenue of US$15,034 million and a net loss of US$248 million, alongside US$4.30 billion in non-cash intangible asset impairments and a modest increase in full-year 2026 revenue guidance to US$60.50–US$62.50 billion. A key offsetting highlight was the positive Phase 3 data for Pfizer’s autoimmune drug LITFULO in nonsegmental vitiligo, underlining the growing importance of its non-COVID portfolio and broader immunology...

Novo Nordisk (CPSE:NOVO B) faces fresh competition as the UK's MHRA approves Eli Lilly's oral weight loss therapy Foundayo for use in the country. The approval adds a non injectable option alongside Novo Nordisk's GLP 1 based obesity drugs and could affect demand patterns if Foundayo is adopted in public healthcare settings. In the US, Amazon Pharmacy launches a new Medicare weight loss drug program priced at $50 per month that will include Novo Nordisk and Eli Lilly medications. These...

Wingstop (WING) shares are in focus after the company expanded its board to eleven members and appointed PENN Entertainment chief executive Jay Snowden as an independent Class II director on August 6, 2026. See our latest analysis for Wingstop. Wingstop’s recent board refresh comes after a tough stretch for shareholders, with the share price down 56.36% year to date and the 1-year total shareholder return declining 67.1%. However, the 1-day share price return of 0.65% hints at some short-term...

Fabrinet (FN) drew fresh attention after announcing that its management will speak at the Rosenblatt 6th Annual Age of AI Technology Summit on August 18, 2026, with investors able to access a live webcast. See our latest analysis for Fabrinet. The recent announcement around Fabrinet's appearance at the AI summit comes as momentum in the stock has picked up again, with a 1 month share price return of 20.49% and a year to date share price return of 19.29%. The 1 year total shareholder return of...

The AI-driven memory shortage strikes again.

KEYS heads into its Q3 results with new testing and software offerings targeting growth in AI, data centers and photonics.

Axon's strong Q2 revenue growth and raised outlook support its long-term prospects, but high costs, debt and valuation temper near-term appeal.

Nvidia has a plan to make sure its GPUs won't lose value. It wants to convince a new crop of financiers to keep lending for AI buildouts.